Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.

Hagger D, Condliffe R, Woodhouse N, Elliot CA, Armstrong IJ, Davies C, Hill C, Akil M, Wild JM, Kiely DG.

Rheumatology (Oxford). 2009 Sep;48(9):1137-42. doi: 10.1093/rheumatology/kep187. Epub 2009 Jul 14.

PMID:
19605369
2.

Updated clinical classification of pulmonary hypertension.

Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-54. doi: 10.1016/j.jacc.2009.04.012. Review.

3.

Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, Corretti MC, Hassoun PM.

Am J Respir Crit Care Med. 2009 Apr 1;179(7):615-21. doi: 10.1164/rccm.200811-1691OC. Epub 2009 Jan 22.

4.

Right ventricular function in scleroderma-related pulmonary hypertension.

Vonk Noordegraaf A, Naeije R.

Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v42-3. doi: 10.1093/rheumatology/ken284. Review.

PMID:
18784141
5.

Cardiac cine MRI: Quantification of the relationship between fast gradient echo and steady-state free precession for determination of myocardial mass and volumes.

Malayeri AA, Johnson WC, Macedo R, Bathon J, Lima JA, Bluemke DA.

J Magn Reson Imaging. 2008 Jul;28(1):60-6. doi: 10.1002/jmri.21405.

6.

Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension.

Sanz J, Dellegrottaglie S, Kariisa M, Sulica R, Poon M, O'Donnell TP, Mehta D, Fuster V, Rajagopalan S.

Am J Cardiol. 2007 Aug 15;100(4):731-5. Epub 2007 Jun 27.

PMID:
17697838
7.

Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR.

Dellegrottaglie S, Sanz J, Poon M, Viles-Gonzalez JF, Sulica R, Goyenechea M, Macaluso F, Fuster V, Rajagopalan S.

Radiology. 2007 Apr;243(1):63-9.

PMID:
17392248
8.

Epidemiology of pulmonary arterial hypertension.

Taichman DB, Mandel J.

Clin Chest Med. 2007 Mar;28(1):1-22, vii. Review.

PMID:
17338925
9.

Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging.

Sanz J, Kuschnir P, Rius T, Salguero R, Sulica R, Einstein AJ, Dellegrottaglie S, Fuster V, Rajagopalan S, Poon M.

Radiology. 2007 Apr;243(1):70-9. Epub 2007 Feb 28.

PMID:
17329691
10.

Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, Postmus PE, Vonk-Noordegraaf A.

Eur Heart J. 2007 May;28(10):1250-7. Epub 2007 Jan 22.

PMID:
17242010
11.

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.

Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L, Krishnan JA, Wigley F, Hassoun PM.

Arthritis Rheum. 2006 Sep;54(9):3043-50.

12.

Cardiac cine MR-imaging at 3T: FLASH vs SSFP.

Tyler DJ, Hudsmith LE, Petersen SE, Francis JM, Weale P, Neubauer S, Clarke K, Robson MD.

J Cardiovasc Magn Reson. 2006;8(5):709-15.

PMID:
16891230
13.

Determination of cardiac volumes and mass with FLASH and SSFP cine sequences at 1.5 vs. 3 Tesla: a validation study.

Hudsmith LE, Petersen SE, Tyler DJ, Francis JM, Cheng AS, Clarke K, Selvanayagam JB, Robson MD, Neubauer S.

J Magn Reson Imaging. 2006 Aug;24(2):312-8.

PMID:
16795076
14.

Analysis of cardiac function--comparison between 1.5 Tesla and 3.0 Tesla cardiac cine magnetic resonance imaging: preliminary experience.

Michaely HJ, Nael K, Schoenberg SO, Laub G, Reiser MF, Finn JP, Ruehm SG.

Invest Radiol. 2006 Feb;41(2):133-40.

PMID:
16428984
15.

Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.

Wilkins MR, Paul GA, Strange JW, Tunariu N, Gin-Sing W, Banya WA, Westwood MA, Stefanidis A, Ng LL, Pennell DJ, Mohiaddin RH, Nihoyannopoulos P, Gibbs JS.

Am J Respir Crit Care Med. 2005 Jun 1;171(11):1292-7. Epub 2005 Mar 4.

PMID:
15750042
16.

Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report.

Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK; European Society of cardiology; Soceity for Cardiovascular Magnetic Resonance.

J Cardiovasc Magn Reson. 2004;6(4):727-65. No abstract available.

PMID:
15646878
17.

Clinical classification of pulmonary hypertension.

Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):5S-12S. Review.

18.

Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure.

Saba TS, Foster J, Cockburn M, Cowan M, Peacock AJ.

Eur Respir J. 2002 Dec;20(6):1519-24.

19.

Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.

Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM.

Am J Respir Crit Care Med. 2003 Mar 1;167(5):735-40. Epub 2002 Dec 12.

PMID:
12480614
20.

Double-chambered right ventricle or sub-infundibular stenosis assessed by cardiovascular magnetic resonance.

Kilner PJ, Sievers B, Meyer GP, Ho SY.

J Cardiovasc Magn Reson. 2002;4(3):373-9.

PMID:
12234109

Supplemental Content

Support Center